Digipharm brings together industry expertise, a mature concept and revolutionary blockchain technology to facilitate the transformation of healthcare to a value-based approach.

Spiralling healthcare costs combined with resource constraints have resulted in an unremitting burden on health systems. Trade-offs need to be made, patients are at risk of being denied innovative treatments and there remains barriers to reimbursement for manufacturers.

Digipharm bypasses infrastructural limitations to enable the implementation of flexible value-based pricing agreements using smart contracts, the development of unprecedented evidence platforms and the ability to reward patients for contributing their data.

Our Vision

To be the pioneer of sustainable and value-based healthcare delivery,
innovative evidence generation and patient empowerment across the healthcare industry.


...

The Future of Healthcare


Value Based Care

Healthcare systems around the world are currently threatened by challenges unique to our time; unsustainable expenditure, ageing populations and the increasing prevalence of chronic diseases. The concept of value based healthcare proposes that payment for healthcare should be tied to the quality of care and the benefits it provides; switching from a ‘fee for service’ to a ‘fee for performance’ reimbursement model.

Innovative Pricing

Innovative pricing solutions such as value-based pricing offer an increasingly dynamic solution to address the uncertainty around the cost of treatment relative to patient outcomes. Such mechanisms reward manufacturers and providers for improving patient outcomes, incentivise innovation and encourage the transition to patient centric healthcare.

Pioneering Evidence Generation

Innovative evidence generation solutions are necessary to satisfy the requirement of relevant, timely and quality data to inform the provision of optimised value based healthcare. Circumventing the use of static or retrospective data will open the horizon to superior forecasting, confidence in decision making and global oversight with regards to current developments in an increasingly dynamic industry such as healthcare.

The Digipharm Difference


Elimination of Barriers

Whilst value based healthcare provides the solution to numerous issues faced by healthcare systems, the extensive uptake of a value-based approach has been hindered by the infrastructural limitations of current health information systems, the administrative burden of its implementation and the fragmentation of health care delivery and patient outcomes data.

Patient Empowerment

Digipharm are strong believers in empowering patients with the custodianship and ownership of their personal data. Patients will be incentivised to share and contribute their health related data to inform decision making and health related research.

Blockchain Technology

Digipharms’ solutions will facilitate and accelerate the paradigm shift to value based and patient centric healthcare using ‘smart contracts’ and blockchain technology. Utilising blockchain technology for Digipharms’ platforms promotes the development of a decentralised health information infrastructure that is ubiquitous, transparent and security conscious.

Our Flagship Solutions


Reimburse Logo

Reimburse will eliminate the infrastructural barriers and automate the implementation of value based pricing agreements, no matter how complex, on a fully independent global platform; encouraging personalised reimbursement of health technology on a ‘fee for performance’ basis for the mutual benefit of patients, payers and manufacturers.

  • Accelerates access to high cost therapy
  • Incentivises innovation
  • Drastically reduces administrative costs
Insights Logo

Insights is the first ever ‘live’ real world evidence repository and allows the utilisation of real world evidence (RWE) as soon as it becomes available. The availability of ‘live’ RWE will provide stakeholders with real time intelligence with which they can inform decision making and product development across the medicinal lifecycle.

  • Incentives for patients to contribute data
  • Significant cost savings compared to conventional RWE sources
  • Single platform for global evidence

Digipharm - Swisscom Blockchain cooperation

Swisscom Blockchain are Digipharms' technical development partners for the development of our flagship solutions.


Swisscom Blockchain Logo

Our Team


Member Image

Ahmed Abdulla

Founder/CEO

Member Image

Girisha Fernando

Co-Founder/COO

Member Image

Zach Daniels

CTO

Member Image

Michel Mohler

Chief Financial Officer

Member Image

Alexander Sverdlov

Cybersecurity Strategy

Member Image

Meredith Darden

Digital Marketing Lead

Member Image

Alexey Popov

Web Development

Member Image

Michael Gubert

UI/UX Design

Member Image

Leon Rebolledo

Lead Architect

Member Image

Rolf Günter

Legal Counsel

Member Image

Ralf Gerteis

Commercial Strategy

Member Image

Dr. Mohamed Abdulla

Clinical Transformation

Member Image

Dr. Hasham Al-Meshhedani

Patient Engagement

Member Image

Ali Al-Sudani

Clinical Pharmacist

Member Image

Dr. Rami Radwan

Clinical Relations

Member Image

Bobby Kaura

Business Development

Member Image

Peter Sandbach

Communications Director

Member Image

Debra De Silva-Sun

HEOR & Pricing Analyst

Member Image

Marko Granic

Graphic Designer

Our Advisors


Member Image

Sven Möller

ICO Advisor
Swisscom Blockchain AG

Member Image

Kamal Youssefi

Enterprise Blockchain Advisor
Swisscom Blockchain AG

Member Image

Waldemar Scherer

Life Sciences Blockchain Advisor
Swisscom Blockchain AG

Member Image

Sam Mantle

Health & Life Sciences Technology Advisor
Luxoft

Member Image

Daniel Heller

PR Advisor
Partner, Farner Consulting AG

Member Image

Claudio Staub

Co-Head Startup Communications
Farner Consulting AG

Member Image

Anas Aman

Quality and Testing
IBM

Member Image

Lloyd Jefferies

CRM Advisor
KPMG

Member Image

Per-Olof Thuresson

Health Economist
Roche

Member Image

Fadi Chehadah

Health Economist
NICE UK

Who we work with